Literature DB >> 29239956

The Anesthesia Workstation: Quo Vadis?

Jan F A Hendrickx1, Andre M De Wolf2.   

Abstract

Ensuring adequate ventilation and oxygenation and delivering inhaled anesthetic agent to the patient remain core responsibilities of the anesthesia provider during general anesthesia. Because of the emphasis placed on physiology, pharmacology, clinical sciences, and administrative duties, the stellar anesthesia workstation technology may be underutilized by the anesthesia community. Target-controlled O2 and agent delivery and automated end-expired CO2 control have entered the clinical arena, with only cost, luddism, and administrative hurdles preventing their more widespread use. This narrative review will explain technological aspects of existing and recently introduced anesthesia workstations. Concepts rather than particular anesthesia machines will be addressed, but examples will mostly pertain to the more recently introduced workstations. The anesthesia workstation consists of a ventilator, a carrier gas and agent delivery system, a scavenging system, and monitors. Mainly, the circle breathing circuit configuration, ventilator, and carrier gas and agent delivery technology are discussed. Occasionally, technical details are provided to give the reader a taste of the modern technology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29239956     DOI: 10.1213/ANE.0000000000002688

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Development and validation of a model to calculate anesthetic agent consumption from inspired and end-expired concentrations, minute ventilation, fresh gas flow and dead space ventilation.

Authors:  Louise Cuveele; Jan F A Hendrickx; Andre M De Wolf; Sofie De Cooman; Brian B Chesebro; Jeffrey Feldman; Jodi Sherman
Journal:  J Clin Monit Comput       Date:  2022-06-16       Impact factor: 2.502

2.  Prospective validation of gas man simulations of sevoflurane in O2/air over a wide fresh gas flow range.

Authors:  Esther Candries; Andre M De Wolf; Jan F A Hendrickx
Journal:  J Clin Monit Comput       Date:  2022-03-22       Impact factor: 2.502

3.  Memsorb™, a novel CO2 removal device part I: in vitro performance with the Zeus IE®.

Authors:  Mohammed K Bashraheel; Sarah A Eerlings; Andre M De Wolf; Arne Neyrinck; Marc Van de Velde; Geert Vandenbroucke; Rik Carette; Jeffrey Feldman; Jan F A Hendrickx
Journal:  J Clin Monit Comput       Date:  2022-01-28       Impact factor: 1.977

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.